
    
      To compare the efficacy and safety of Chinese herbal medicine Qing Re Huo Xue (QRHX) and
      methotrexate (MTX) for patients with active rheumatoid arthritis (RA), a multicenter,
      randomized controlled trial will be conducted. Two hundred and four patients with active RA
      will be randomly allocated (1:1) to treatment with QRHX 10mg bid and MTX 10 mg once a week
      for 24 weeks, or MTX plus dummy QRHX. The primary outcome is he OMERACT rheumatoid arthritis
      MRI scoring system (RAMRIS) at week 24.
    
  